General, N.B. Reg. 2014-27
Section 22
Sale to member of the Plan by participating provider
Cite as General, N.B. Reg. 2014-27, s. 22 · current to November 1, 2026 · read from New Brunswick Acts and Regulations on November 16, 2026
The text
(1) For the purposes of section 25 of the Act, a participating provider shall not charge a member of the Plan an amount that is greater than the amount determined under subsection 27(2) of the Act.
(2) Despite subsection (1), when a prescription is for a brand name product that has a pharmaceutical equivalent or a pharmaceutical alternative and the member of the Plan does not have an approval under subsection 29(4) of the Act for the brand name product, the member shall pay the difference in price between the actual acquisition cost of the brand name product and the maximum allowable price of the lowest cost pharmaceutical equivalent or pharmaceutical alternative if the member elects to receive the brand name product.
(3) A participating provider shall not require a member of the Plan to pay an amount, in addition to a co-payment or an additional charge under subsection (2), as a condition to providing a benefit.
Read the General on the Province's website ↗
Made under Prescription and Catastrophic Drug Insurance Act, 2014, c.4.